Skip to content

Net Income at other companies

Abbott logo
AbbottABT
$1.08B-18.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%
Medtronic logo
MedtronicMDT
$1.24B+17.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%
ITG
Integer HoldingsITGR
$16.51M+173%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s net income?
Pulse Biosciences, Inc. (PLSE) reported net income of -$18.58M in Q1 2026.
How has Pulse Biosciences, Inc.'s net income changed year-over-year?
Pulse Biosciences, Inc.'s net income decreased by 10.6% year-over-year, from -$16.8M to -$18.58M.
What is the long-term trend for Pulse Biosciences, Inc.'s net income?
Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s net income has grown at a 3.4% compound annual growth rate (CAGR), from -$63.66M to -$72.78M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.